rs201471607

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM5PP5_Very_Strong

The NM_000350.3(ABCA4):​c.2894A>G​(p.Asn965Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000075 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N965D) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000075 ( 0 hom. )

Consequence

ABCA4
NM_000350.3 missense

Scores

6
10
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:17

Conservation

PhyloP100: 6.21
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM1
In a hotspot region, there are 10 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_000350.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-94046944-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 99172.Status of the report is criteria_provided_single_submitter, 1 stars.
PP5
Variant 1-94046943-T-C is Pathogenic according to our data. Variant chr1-94046943-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 236096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-94046943-T-C is described in Lovd as [Likely_pathogenic]. Variant chr1-94046943-T-C is described in Lovd as [Pathogenic]. Variant chr1-94046943-T-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.2894A>G p.Asn965Ser missense_variant Exon 19 of 50 ENST00000370225.4 NP_000341.2 P78363Q6AI28
ABCA4NM_001425324.1 linkc.2672A>G p.Asn891Ser missense_variant Exon 18 of 49 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.2894A>G p.Asn965Ser missense_variant Exon 19 of 50 1 NM_000350.3 ENSP00000359245.3 P78363
ABCA4ENST00000649773.1 linkc.2672A>G p.Asn891Ser missense_variant Exon 18 of 19 ENSP00000496882.1 A0A3B3IRV8

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000135
AC:
34
AN:
251332
Hom.:
0
AF XY:
0.000125
AC XY:
17
AN XY:
135826
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000194
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000746
AC:
109
AN:
1461886
Hom.:
0
Cov.:
32
AF XY:
0.0000729
AC XY:
53
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000227
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.0000936
Gnomad4 NFE exome
AF:
0.0000719
Gnomad4 OTH exome
AF:
0.0000662
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152202
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000889
Hom.:
0
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000173
AC:
21
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe early-childhood-onset retinal dystrophy Pathogenic:3
Jan 01, 2016
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 05, 2025
SingHealth Duke-NUS Institute of Precision Medicine
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant is located in a mutational hotspot where >50% of variants are pathogenic (PM1) + Homozygous allele count in gnomAD exomes and genomes are less than 0 (PM2). Other variants on this amino acid residue have been classified as pathogenic (PM5, p.Asn965Asp, p.Asn965Ile, p.Asn965Lys). REVEL score is 0.779 (PP3_mod). + Variant is found to be in trans with another pathogenic variant (PM3, internal data). Study has shown the variant affects the function of the protein (PS3, PMID:29145636) -

Mar 30, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change is predicted to replace asparagine with serine at codon 965 of the ABCA4 protein, p.(Asn965Ser). The asparagine residue is moderately conserved (100 vertebrates, UCSC), and is located within the Walker A motif in the ATP binding cassette transporter 1 domain, critical for nucleotide phosphate binding (PMID: 29145636). There is a small physicochemical difference between asparagine and serine. The variant is present in a large population cohort at a frequency of 0.01%, which is consistent with recessive disease (rs201471607, 35/282,722 alleles, 0 homozygotes in gnomAD v2.1). It has been identified in the homozygous state and compound heterozygous with a second pathogenic allele in multiple cases with retinal disorders including Stargadt disease, fundus flavimaculatus, retinitis pigmentosa, cone-rod dystrophy, and Bull's eye maculopathy (PMID: 17982420 , 20647261). Further, a p.Asn965Ser knock-in mouse model recapitulates the phenotype of Stargardt disease patients and Abca4 knockout mice (PMID: 29145636). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (6/7 algorithms). Based on the classification scheme RMH ACMG Guidelines v1.2.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PS3, PM1, PM2, PP3. -

not provided Pathogenic:3
Jun 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ABCA4: PM3:Very Strong, PM1, PM2, PM5:Supporting, PS3:Supporting -

Jun 16, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Published functional studies demonstrate a damaging effect with partial misfolding of the protein with mislocalization and low ATPase activity (Molday et al., 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 9054934, 27739528, 28446513, 27939946, 28118664, 22968130, 25356976, 24453473, 24713488, 26780318, 28327576, 28704108, 29126757, 24097981, 21226556, 30204727, 29925512, 30718709, 30093795, 31456290, 32845050, 32845068, 32531858, 33732702, 32619608, 33090715, 33691693, 33301772, 33261146, 32244552, 17982420, 28559085, 29145636) -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 965 of the ABCA4 protein (p.Asn965Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with ABCA4-related disease and/or Stargardt disease (PMID: 17982420, 25356976, 27739528, 28559085). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 236096). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCA4 function (PMID: 22735453, 24097981, 29145636). For these reasons, this variant has been classified as Pathogenic. -

Retinal dystrophy Pathogenic:3
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

Jan 01, 2020
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 12, 2019
Blueprint Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stargardt disease Pathogenic:2
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Stargardt disease 3 Pathogenic:1
-
Ophthalmo-Genetics Lab, Instituto de Oftalmologia Conde de Valenciana
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Macular dystrophy Pathogenic:1
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Cone-rod dystrophy Pathogenic:1
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Retinitis pigmentosa 19 Pathogenic:1
Jan 03, 2024
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.021%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000419605 /PMID: 21039602 /3billion dataset). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

Severe early-childhood-onset retinal dystrophy;C1858806:Cone-rod dystrophy 3;C1866422:Retinitis pigmentosa 19;C3495438:Age related macular degeneration 2 Pathogenic:1
-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PM2_Supporting+PM3_VeryStrong+PP3_Moderate -

Retinitis pigmentosa Pathogenic:1
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.044
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.86
D;.
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Pathogenic
0.55
D
MetaRNN
Uncertain
0.63
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.9
L;.
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-4.6
D;.
REVEL
Pathogenic
0.78
Sift
Uncertain
0.012
D;.
Sift4G
Uncertain
0.0030
D;.
Polyphen
1.0
D;.
Vest4
0.81
MVP
0.97
MPC
0.42
ClinPred
0.32
T
GERP RS
5.5
Varity_R
0.72
gMVP
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201471607; hg19: chr1-94512499; API